| 000 | 01625 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517113437.0 | ||
| 264 | 0 | _c20180319 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1432-198X | ||
| 024 | 7 |
_a10.1007/s00467-016-3474-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrakemeier, S | |
| 245 | 0 | 0 |
_aTreatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients. _h[electronic resource] |
| 260 |
_bPediatric nephrology (Berlin, Germany) _cJul 2017 |
||
| 300 |
_a1137-1144 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiomyolipoma _xdiagnosis |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aEmbolization, Therapeutic |
| 650 | 0 | 4 |
_aEverolimus _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xphysiopathology |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xdiagnosis |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSirolimus _xtherapeutic use |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTuberous Sclerosis _xcomplications |
| 650 | 0 | 4 | _aTuberous Sclerosis Complex 1 Protein |
| 650 | 0 | 4 | _aTuberous Sclerosis Complex 2 Protein |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 700 | 1 | _aBachmann, F | |
| 700 | 1 | _aBudde, K | |
| 773 | 0 |
_tPediatric nephrology (Berlin, Germany) _gvol. 32 _gno. 7 _gp. 1137-1144 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00467-016-3474-6 _zAvailable from publisher's website |
| 999 |
_c26381795 _d26381795 |
||